Drooping tissue atrophy following chelation therapy
I have heard from a few female patients that they have experienced either drooping/sagging facial tissue and/or atrophy of tissue (such as in the hands) . Some times this has been a continuation of ongoing process from GDD and others apparently just after chelation, also when otherwise the chelation seems to be improving their overfall condition.
I have spent some time thinking about these phenomena, and now I am ready to explain my theory on this. There are likely 2 essential components:
1. Gd has inserted itself into the architecture of various tissues, maybe all tissues but certainly skin and bone, where the highest amounts of Gd are deposited. Even though it is a faulty architecture with the foreign substance inserted (often in replacement for Ca or a Ca-containing molecule) it is nonetheless architecture. Pulling the Gd out is like that game where there is a tower of blocks and various players try to pull out a block from lower down in the tower, and eventually pulling out one block causes the entire tower to fall. It is like that: Gd molecules are pulled out of supporting tissue (probably largely collagen) and eventually some of it collapses.
2. Another cellular effect is also likely occurring. Immune cells, and I drew attention in a few blogs back, the Langerhans cell, which is an immune cell that resides predominantly in skin, are constantly reacting to the presence of Gd, releasing cytokines and other products, and a prominent feature of this inflammatory effect is increasing local tissue fluid, which creates tissue bulk. Now some of that bulk no doubt hides underlying existent atrophy, due to disuse atrophy and also direct toxic effects of Gd and host cell reaction that has occurred with the original GDD disease. Decreasing the inflammation by decreasing the presence of Gd therefore unmasks atrophy that was already there. Decreasing fibrosis also causes loss of the pathological architecture that was also creating a supportive network.
I am currently looking into approaches to restore collagen and other supportive tissues that will counter these effects.
Richard Semelka MD Consulting Stay tuned on the latest advancements: